SCHEMBL2197140

SCHEMBL2197140

C[C@@H]1CN(C)[C@@H](C)CN1c1ccc([N+](=O)[O-])cc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.48
LMNA P02545 3/20 0.48
MAPT P10636 3/20 0.48
KMT2A Q03164 1/20 0.48
THRB P10828 1/20 0.43
KDM4E B2RXH2 1/20 0.41
GAA P10253 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
RECQL P46063 1/20 0.40
WDR5 P61964 1/20 0.40
HTT P42858 2/20 0.40
CASP1 P29466 1/20 0.39
CASP3 P42574 1/20 0.39
CASP4 P49662 1/20 0.39
CASP7 P55210 1/20 0.39
CASP9 P55211 1/20 0.39
CASP6 P55212 1/20 0.39
HIF1A Q16665 1/20 0.39
GABRA1 P14867 1/20 0.38
GABRG2 P18507 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12424151 1.00 ALDH1A1 (0.48) ALDH1A1LMNAMAPTKMT2ATHRB
SCHEMBL10126832 0.84 RECQL (0.41) ALDH1A1LMNAMAPTKDM4EGAA
SCHEMBL16305346 0.84 RECQL (0.41) ALDH1A1LMNAMAPTKDM4EGAA
SCHEMBL4812720 0.81 ALDH1A1 (0.64) ALDH1A1LMNAMAPTKMT2ATHRB
SCHEMBL2197225 0.80 ALDH1A1 (0.49) ALDH1A1LMNAMAPTKMT2ATHRB
SCHEMBL12424147 0.80 ALDH1A1 (0.49) ALDH1A1LMNAMAPTKMT2ATHRB
SCHEMBL13419591 0.79 ALDH1A1 (0.57) ALDH1A1LMNAMAPTKMT2ATHRB
SCHEMBL16569962 0.79 ALDH1A1 (0.48) ALDH1A1LMNAMAPTKMT2ATHRB
SCHEMBL16569961 0.79 ALDH1A1 (0.48) ALDH1A1LMNAMAPTKMT2ATHRB
SCHEMBL1047097 0.78 ALDH1A1 (0.58) ALDH1A1LMNAMAPTKMT2ATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977352-B2 Triazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases GALAPAGOS NV (BE) 2011-07-12 US disclosed